Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sanam Sane"'
Autor:
Sanam Sane, Andre Hafner, Rekha Srinivasan, Daniall Masood, John l. Slunecka, Collin J. Noldner, Alex D. Hanson, Taylor Kruisselbrink, Xuejun Wang, Yiyang Wang, Jun Yin, Khosrow Rezvani
Publikováno v:
Molecular Oncology, Vol 12, Iss 10, Pp 1753-1777 (2018)
Overexpression of oncoproteins is a major cause of treatment failure using current chemotherapeutic drugs. Drug‐induced degradation of oncoproteins is feasible and can improve clinical outcomes in diverse types of cancers. Mortalin‐2 (mot‐2) is
Externí odkaz:
https://doaj.org/article/8142dff1e9974bd79806dd9c3d84c9be
Autor:
Lydia Lang, Ryan M. Antony, Morgan Eikanger, Grigoriy Sereda, Khosrow Rezvani, Rashaun A Potts, Sanam Sane, Nisitha Wellala Wijewantha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebf887d8b3add72797f9df9b93bc90f
https://doi.org/10.1021/scimeetings.3c00116
https://doi.org/10.1021/scimeetings.3c00116
Autor:
Sanam Sane, Rekha Srinivasan, Rashaun A. Potts, Morgan Eikanger, Diana Zagirova, Jessica Freeling, Casey A. Reihe, Ryan M. Antony, Brij K. Gupta, Douglas Lynch, Jonathan Bleeker, Hassan Turaihi, Angela Pillatzki, Wei Zhou, Xu Luo, Michael Linnebacher, Diing Agany, Etienne Gnimpieba Zohim, Lisa E. Humphrey, Adrian R. Black, Khosrow Rezvani
Publikováno v:
Oncogene
The mTORC2 pathway plays a critical role in promoting tumor progression in human colorectal cancer (CRC). The regulatory mechanisms for this signaling pathway are only partially understood. We previously identified UBXN2A as a novel tumor suppressor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cb188f1c620b649968cc1a267819cc
https://europepmc.org/articles/PMC10287065/
https://europepmc.org/articles/PMC10287065/
Autor:
Nisitha Wijewantha, Sanam Sane, Morgan Eikanger, Ryan M. Antony, Rashaun A. Potts, Lydia Lang, Khosrow Rezvani, Grigoriy Sereda
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1145
Volume 15
Issue 4
Pages: 1145
This study is focused on the selective delivery and release of the plant-based anticancer compound eugenol (EUG) in colorectal cancer cells (CRC). EUG is an apoptotic and anti-growth compound in diverse malignant tumors, including CRC. However, EUG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74db3cdf6347a2617f45b6eab1ba6557
Autor:
Khosrow Rezvani, Sanam Sane, Rekha Sriniva, Rashaun Potts, Morgan Eikanger, Diana Zagirova, Jessica Freeling, Casey Reihe, Ryan Antony, Brij Gupta, Douglas Lynch, Jonathan Bleeker, Hassan Turaihi, Angela Pillatzki, Wei Zhou, Xu Luo, Diing Agany, Etienne Zohim, Lisa Humphrey, Adrian Black
The mTORC2 pathway plays a critical role in promoting tumor progression in human colorectal cancer (CRC). The regulatory mechanisms for this signaling pathway are only partially understood. We previously identified UBXN2A as a novel tumor suppressor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c869874a2ff3513fe0059910369c19
https://doi.org/10.21203/rs.3.rs-1867481/v1
https://doi.org/10.21203/rs.3.rs-1867481/v1
Autor:
Rekha Srinivasan, Jun Yin, Yiyang Wang, Daniall Masood, Alex D. Hanson, Collin J. Noldner, Xuejun Wang, Andre Hafner, Sanam Sane, Taylor Kruisselbrink, John l. Slunecka, Khosrow Rezvani
Publikováno v:
Molecular Oncology, Vol 12, Iss 10, Pp 1753-1777 (2018)
Molecular Oncology
Molecular Oncology
Overexpression of oncoproteins is a major cause of treatment failure using current chemotherapeutic drugs. Drug‐induced degradation of oncoproteins is feasible and can improve clinical outcomes in diverse types of cancers. Mortalin‐2 (mot‐2) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1af750bec9edf096aaddf7f1dc40959
https://doaj.org/article/8142dff1e9974bd79806dd9c3d84c9be
https://doaj.org/article/8142dff1e9974bd79806dd9c3d84c9be
Autor:
Morgan E. Nelson, Ammara Abdullah, Sanam Sane, Samuel S. Newton, Khosrow Rezvani, Subhash C. Chauhan, Hongmin Wang
Publikováno v:
Cell Stress and Chaperones. 21:313-326
Overexpression of the oncoprotein mortalin in cancer cells and its protein partners enables mortalin to promote multiple oncogenic signaling pathways and effectively antagonize chemotherapy-induced cell death. A UBX-domain-containing protein, UBXN2A,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3ead33778ca0d4a15ff2f924103faa
https://doi.org/10.1007/s12192-015-0661-5
https://doi.org/10.1007/s12192-015-0661-5
Publikováno v:
Cancer Research. 80:3934-3934
Despite advances in treatment regimens, one-third of colorectal cancer (CRC) patients will die from this metastatic disease that can disseminate, or spread, throughout the body. Therefore, understanding the mechanisms underlying the multistep metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35752d40eb4fe62711cfb9e8ed08cc40
https://doi.org/10.1158/1538-7445.am2020-3934
https://doi.org/10.1158/1538-7445.am2020-3934
Autor:
Hongmin Wang, Dong Zhang, Khosrow Rezvani, Ammara Abdullah, Jessica Freeling, Sanam Sane, Kate A. Branick
Publikováno v:
Oncotarget
// Ammara Abdullah 1 , Sanam Sane 1 , Kate A. Branick 1 , Jessica L. Freeling 1 , Hongmin Wang 1 , Dong Zhang 2 , Khosrow Rezvani 1 1 Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, Vermillion, SD 57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f79daa494937487344d7b65ee5901d0
https://doi.org/10.18632/oncotarget.4452
https://doi.org/10.18632/oncotarget.4452
Publikováno v:
Journal of Cancer
The subcellular localization, expression level, and activity of anti-cancer proteins alter in response to intrinsic and extrinsic cellular stresses to reverse tumor progression. The purpose of this study is to determine whether UBXN2A, an activator o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97bfe708df790c9982b4f8eea737c3a1
https://doi.org/10.7150/jca.12134
https://doi.org/10.7150/jca.12134